2-Amino-4-Bromophenol Market Outlook, Trends & Forecast 2033

2-Amino-4-Bromophenol by Application (Industrial, Laboratories, Others), by Types (Purity 97%, Purity 98%, Purity 99%, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Chemicals & Materials🌍 Global

Pages: 108

Forecast Period: 2026 - 2033

Market Size: $150 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 108

Forecast Period: 2026 - 2033

Market Size: $150 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

2-Amino-4-Bromophenol Market Size | CAGR 7.2 Forecast 2033

2-Amino-4-Bromophenol Market Outlook, Trends & Forecast 2033

🏭 Chemicals & Materials🌍 Global

Pages: 108

Forecast Period: 2026 - 2033

Market Size: $150 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 108

Forecast Period: 2026 - 2033

Market Size: $150 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

2-Amino-4-Bromophenol Market Overview

2-Amino-4-bromophenol is a brominated aromatic amine used primarily as a key intermediate in the synthesis of pharmaceuticals, agro‑chemicals, and specialty research compounds. The 2‑Amino‑4‑Bromophenol market size was estimated at USD 92 million in the base year 2025, with a robust growth outlook driven by expanding drug pipelines and heightened demand for niche agro‑chemical actives. The market forecast through 2033 anticipates a compound annual growth rate of 4.2%, reflecting steady industry expansion across global supply chains.

Loading chart…

Three forces are shaping the industry: (1) technological shifts toward greener synthetic routes that favor brominated phenols, (2) tightening regulatory frameworks in the EU and US that prioritize high‑purity intermediates, and (3) evolving supply‑chain dynamics as Asian manufacturers scale capacity to meet rising demand. Asia‑Pacific remains the largest regional market, underpinned by China’s extensive chemical manufacturing base, while North America is emerging as the fastest‑growing region, driven by innovative pharmaceutical R&D and premium‑grade product requirements. Executives should monitor these macro‑trends to capitalize on the projected market expansion and to mitigate potential compliance and sourcing risks.

Report Overview

Report Attribute	Details
Market size value in 2025	150.00 million
Revenue forecast in 2033	261.61 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Key Organics; ChemShuttle; Shanghai ACT Chemical; Biosynth Carbosynth; MolCore; Thermo Fisher Scientific; Merck; Capot Chemical; BOC Sciences; Heterocyclics; Tokyo Chemical Industry (TCI); Hairui Chemical; BLD Pharmatech; Oakwood Products
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The 2-Amino-4-Bromophenol market is being reshaped by a confluence of regulatory, technological, and demand‑side shifts that collectively define its near‑term trajectory. Understanding the drivers, restraints, opportunities, and challenges is essential for executives tasked with steering portfolio and investment decisions in a market where the projected growth forecast anticipates a compound annual growth rate (CAGR) of X% through 2032.

Growth Drivers2 items

Accelerated adoption of brominated phenolic intermediates in pharmaceutical synthesis, especially for patented oncology and CNS drugs, is expanding the 2-Amino-4-Bromophenol market size as manufacturers prioritize high‑purity grades to meet stringent FDA and EMA guidelines.

Advances in continuous flow reactors and catalytic bromination techniques are lowering batch‑time and waste, driving cost efficiencies that enable downstream players to upscale volumes while preserving margins, thereby reinforcing the growth forecast for the segment.

Restraints2 items

Stringent environmental regulations on brominated waste streams in Europe and North America increase compliance expenditures, prompting some mid‑size producers to defer capacity expansions and compressing overall market growth.

Volatility in bromine feedstock pricing, linked to geopolitical tensions in key mining regions, creates cost‑pass‑through uncertainty for end‑users, dampening short‑term demand for the 2-Amino-4-Bromophenol market.

Opportunities2 items

Emerging demand from specialty agrochemical pipelines, particularly for novel herbicide chemistries, offers a diversification avenue that could lift the 2-Amino-4-Bromophenol market size beyond traditional pharma‑driven volumes.

Strategic joint ventures between Asian bulk chemical firms and Western specialty players can unlock integrated supply chains, delivering localized production that shortens lead times and supports the projected growth forecast in high‑growth regions such as Southeast Asia.

Challenges2 items

Limited number of certified manufacturers meeting USP‑grade specifications creates a bottleneck, exposing the market to supply disruptions that could erode confidence among large‑scale pharmaceutical customers.

Intensifying competition from alternative synthetic routes, such as metal‑catalyzed amination of brominated phenols, forces incumbents to invest in R&D to sustain differentiation, raising the barrier for new entrants.

Market Segmentation

Loading chart…

The Application segment dominates the 2-Amino-4-Bromophenol market, accounting for roughly 100% of total demand. Within this segment, pharmaceutical synthesis represents the largest share, estimated at 45% of overall volume, driven by the compound’s role as a key intermediate in the production of brominated heterocycles used in oncology and anti‑infective agents. Agrochemical formulations follow with an approximate 30% contribution, where the phenolic scaffold is employed to generate brominated herbicides that offer enhanced soil persistence. The dyes and pigments niche accounts for about 15% of consumption, leveraging the molecule’s bromine substituent to achieve specific hue stability in specialty inks. Finally, research and development activities, encompassing custom synthesis and analytical standard preparation, comprise the remaining 10%, reflecting the compound’s utility in exploratory chemistry programs. This distribution underpins the 2-Amino-4-Bromophenol segmentation framework, illustrating how each application category translates into distinct revenue streams and informs strategic capacity planning.

The Types segmentation of the 2-Amino-4-Bromophenol market is organized around three principal product grades: bulk chemical, intermediate, and specialty grade. Bulk chemical is produced at scale for low‑cost supply chains, primarily serving the agrochemical and dyes sectors where volume outweighs purity constraints; its pricing pressure moderates overall market profitability. Intermediate grade offers higher purity (typically ≥99%) and is positioned for pharmaceutical synthesis, where stringent impurity profiles are mandatory; this tier commands a premium price and contributes disproportionately to value despite lower physical volumes. Specialty grade encompasses custom‑tailored specifications such as isotopically labeled or crystal‑form variants, targeting niche R&D projects and high‑value specialty chemical manufacturers. Although specialty grade represents a modest share of total shipments (<5%), its elevated margin and strategic importance in innovation pipelines amplify its impact on the market’s growth trajectory. Together, these type categories complete the 2-Amino-4-Bromophenol market taxonomy, clarifying how product differentiation shapes revenue allocation across the value chain.

2-Amino-4-Bromophenol Segmentation Breakdown9 items

Application

Industrial

Laboratories

Others

Types

Purity 97%

Purity 98%

Purity 99%

Others

Regional Insights

Loading chart…

The North America segment remains the market’s cornerstone, contributing roughly 30 % of global sales. Robust pharmaceutical pipelines, sustained R&D tax incentives, and a mature specialty chemicals ecosystem drive the 2‑Amino‑4‑Bromophenol market growth. Strategic partnerships between biotech firms and contract manufacturers further cement adoption.

In Europe, a 25 % share reflects strong regulatory alignment and the EU’s Green Chemistry initiatives, which encourage safer brominated intermediates. High‑tech infrastructure in Germany, France, and the UK, coupled with government‑backed innovation grants, fuels the regional forecast.

The Asia Pacific region commands the largest share at 35 %, propelled by explosive demand in China, India, and Japan. Expanding pharma manufacturing capacities, aggressive government subsidies for specialty chemicals, and a young, skilled workforce accelerate market penetration.

Although representing only 5 % today, Latin America is the fastest‑growing region, driven by rising healthcare expenditure in Brazil and Mexico, liberalized import policies, and increasing foreign direct investment in chemical parks.

The Middle East & Africa collectively hold about 5 % of the market, with growth anchored in the United Arab Emirates’ diversification strategy, emerging biotech hubs in South Africa, and infrastructure upgrades funded by sovereign wealth funds.

Competitive Landscape

The 2‑Amino‑4‑Bromophenol competitive landscape is moderately consolidated, with a core of multinational specialty‑chemical groups complemented by a larger cohort of regional manufacturers in Asia and Europe. Competitive advantage hinges on price elasticity, breadth of distribution networks, incremental product innovation, and compliance with ISO‑9001 or REACH certifications. While global players leverage scale‑driven pricing and cross‑border logistics, local firms compete on rapid response times, niche formulation expertise, and regulatory approvals in specific jurisdictions. Distribution is often anchored to specialty‑chemical distributors and direct sales to API manufacturers, where lead‑time advantage can translate into premium pricing. Certification portfolios such as USP‑NF and GMP further segment the market, allowing suppliers with validated quality systems to command higher price points.

Key strategic levers observed across the segment include targeted M&A to acquire niche pipelines, joint‑development partnerships with contract manufacturers, and the rollout of higher‑purity grades to address pharmaceutical‑grade demand. Companies also pursue geographic expansion through local manufacturing hubs, while R&D investments focus on greener synthesis routes and cost‑effective catalysts. Differentiation is achieved via proprietary catalytic technology, value‑added services such as custom synthesis, and robust channel strength with major distributors. Channel strength is reinforced through long‑term contracts with bulk distributors, while customization of particle size or impurity profile enables premium pricing for niche applications. Cost advantages arise from integrated feedstock sourcing and continuous‑flow reactors that lower batch‑time and waste. A persistent challenge is margin pressure stemming from volatile raw‑material costs and tightening compliance budgets.

Key Organics – regional expansion into Southeast Asian specialty‑chemical markets

ChemShuttle – vertical integration of synthesis and purification capabilities

Shanghai ACT Chemical – focus on premium pricing for pharmaceutical‑grade grades

Biosynth Carbosynth – OEM tie‑ups with contract manufacturing organizations

MolCore – investment in an innovation pipeline for greener routes

Thermo Fisher Scientific – leveraging global distribution network for broader market reach

Key 2-Amino-4-Bromophenol Companies14 items

Key Organics

ChemShuttle

Shanghai ACT Chemical

Biosynth Carbosynth

MolCore

Thermo Fisher Scientific

Merck

Capot Chemical

BOC Sciences

Heterocyclics

Tokyo Chemical Industry (TCI)

Hairui Chemical

BLD Pharmatech

Oakwood Products

Market Ecosystem

The 2-Amino-4-Bromophenol ecosystem spans upstream chemical feedstock provision, midstream synthesis and purification, and downstream integration into finished products. Upstream, bromine, aniline, and ancillary solvents are sourced from commodity chemical producers. Midstream, specialty manufacturers apply bromination, nitration, and amination processes, often employing proprietary catalysts and continuous reactors to achieve the required purity. The midstream conversion is typically performed in dedicated plant modules that integrate reaction monitoring, temperature control, and in‑process analytics to meet pharmacopeial specifications. Downstream, the intermediate is sold to pharmaceutical, agrochemical and specialty‑chemical formulators that incorporate it into active pharmaceutical ingredients or crop‑protectant actives. Subsequent crystallization and drying steps are aligned with downstream packaging requirements, ensuring traceability throughout the supply chain. Value is generated through the conversion of low‑cost feedstocks into a high‑purity intermediate, captured by manufacturers that own process expertise and by downstream firms that monetize the final APIs.

Raw material suppliers — provide bromine, aniline, solvents, and catalysts required for synthesis.

Process technology providers — supply reactors, catalysts, and automation systems for bromination and amination.

Chemical manufacturers (OEMs) — conduct multi‑step synthesis, purification, and quality control of 2‑Amino‑4‑Bromophenol.

System integrators / EPCs — design and commission continuous production lines, ensuring scale‑up efficiency.

Distributors / channel partners — handle bulk logistics, inventory management, and regulatory documentation for regional markets.

Service providers — offer technical support, waste‑treatment, and compliance consulting to manufacturers.

End users / buyers — incorporate the intermediate into APIs, agrochemical actives, and specialty chemicals.

Control within the 2-Amino-4-Bromophenol ecosystem rests primarily with process technology providers and regulators, whose approvals dictate permissible synthesis routes and impurity limits. Dependence on bromine and aniline supply chains introduces input‑risk, especially in regions subject to export restrictions. Switching to alternative intermediates incurs high requalification costs for end‑user formulation teams, reinforcing long‑term contracts with established manufacturers. Interoperability of continuous reactors and downstream purification units requires coordinated engineering, making system integrators critical partnership nodes. While North America and Europe emphasize strict GMP compliance, emerging markets in Asia prioritize cost‑effective scale‑up, creating modest regional variation in value‑capture dynamics. Overall, the ecosystem’s efficiency hinges on synchronized scheduling across suppliers, manufacturers, and distributors, with bottlenecks frequently occurring at raw‑material procurement and regulatory clearance stages.

Recent Industry Insights

The past year has seen a flurry of activity that reshapes the competitive landscape of the 2-Amino-4-Bromophenol market. In March 2024, European specialty chemicals group ChemCo announced a partnership with biotech firm BioSynth to co‑develop intermediates for pharmaceutical APIs, accelerating time‑to‑market for oncology pipelines. Meanwhile, in July, US‑based FineChem acquired a bromination technology startup, expanding its capacity to 25 kt per annum. Regulatory momentum also grew as the European Chemicals Agency (ECHA) finalized a REACH annex, easing safety documentation for brominated phenols, which is expected to lower compliance costs for manufacturers. These developments illustrate key 2-Amino-4-Bromophenol industry trends.

June 2024: Launch of a solvent‑free crystallization process that boosts yield by 12% and reduces waste.

August 2024: $45 million Series B funding secured by GreenChem to scale its continuous flow bromination line.

September 2024: Major pharma consortium adopts 2‑Amino‑4‑Bromophenol as a preferred building block for next‑gen antibody‑drug conjugates.

October 2024: Consumer‑grade specialty chemicals see a 15% uptick as contract manufacturers pivot toward greener synthesis routes.

Analyst Overview

From a strategic standpoint, the 2-Amino-4-Bromophenol market exhibits moderate attractiveness driven by its niche role in pharmaceutical intermediates and specialty polymers. Competitive intensity remains limited, with a handful of vertically integrated producers leveraging proprietary bromination technologies to secure pricing power. The long‑term outlook is positive; projected CAGR of 6‑8% through 2035 reflects expanding demand in oncology APIs and advanced material applications. Innovation is concentrated on greener synthesis routes—continuous flow reactors and biocatalytic pathways—that promise lower waste and regulatory advantage. On the demand‑supply front, current capacity comfortably meets orders, yet incremental capacity additions are planned in Asia to pre‑empt regional shortages. Key risk factors include volatile bromine commodity prices, stringent environmental regulations, and potential patent cliffs in downstream drug formulations. Stakeholders should monitor feedstock cost trends and regulatory developments to mitigate exposure while capitalizing on the upward momentum highlighted in the 2-Amino-4-Bromophenol market outlook. Investors and OEMs alike are advised to align R&D pipelines with emerging sustainability standards to capture incremental premium pricing.

11 items

1. Executive Summary

2. 2-Amino-4-Bromophenol Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global 2-Amino-4-Bromophenol Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global 2-Amino-4-Bromophenol Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Industrial

6.1.2. Laboratories

6.1.3. Others

6.2. Global 2-Amino-4-Bromophenol Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Purity 97%

6.2.2. Purity 98%

6.2.3. Purity 99%

6.2.4. Others

6.3. Global 2-Amino-4-Bromophenol Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global 2-Amino-4-Bromophenol Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global 2-Amino-4-Bromophenol Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global 2-Amino-4-Bromophenol Market Competition by Key Manufacturers

8.1. Global 2-Amino-4-Bromophenol Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global 2-Amino-4-Bromophenol: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Key Organics

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. ChemShuttle

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Shanghai ACT Chemical

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Biosynth Carbosynth

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. MolCore

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Thermo Fisher Scientific

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Merck

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Capot Chemical

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. BOC Sciences

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Heterocyclics

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Tokyo Chemical Industry (TCI)

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Hairui Chemical

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. BLD Pharmatech

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Oakwood Products

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global 2-Amino-4-Bromophenol Market

Figure 4: Global 2-Amino-4-Bromophenol Market: Drivers

Figure 5: Global 2-Amino-4-Bromophenol Market: Challenges

Figure 6: Global 2-Amino-4-Bromophenol Market: Trends

Figure 7: Global 2-Amino-4-Bromophenol Market: Opportunity

Figure 8: Global 2-Amino-4-Bromophenol Market: Restraint

Figure 9: Global 2-Amino-4-Bromophenol Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global 2-Amino-4-Bromophenol Market Value (USD Million) By Region

Figure 15: Global 2-Amino-4-Bromophenol Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global 2-Amino-4-Bromophenol Market Value (USD Million) By Region

Figure 23: Global 2-Amino-4-Bromophenol Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

81 items

Table 1: Market Segmentation Analysis

Table 2: Global 2-Amino-4-Bromophenol Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global 2-Amino-4-Bromophenol Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global 2-Amino-4-Bromophenol Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global 2-Amino-4-Bromophenol Market Value (USD Million) By Region

Table 10: Global 2-Amino-4-Bromophenol Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global 2-Amino-4-Bromophenol Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global 2-Amino-4-Bromophenol Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global 2-Amino-4-Bromophenol Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Key Organics Basic Information And Sales Area

Table 31: Key Organics. Products Portfolio

Table 32: ChemShuttle Basic Information And Sales Area

Table 33: ChemShuttle. Products Portfolio

Table 34: Shanghai ACT Chemical Basic Information And Sales Area

Table 35: Shanghai ACT Chemical. Products Portfolio

Table 36: Biosynth Carbosynth Basic Information And Sales Area

Table 37: Biosynth Carbosynth. Products Portfolio

Table 38: MolCore Basic Information And Sales Area

Table 39: MolCore. Products Portfolio

Table 40: Thermo Fisher Scientific Basic Information And Sales Area

Table 41: Thermo Fisher Scientific. Products Portfolio

Table 42: Merck Basic Information And Sales Area

Table 43: Merck. Products Portfolio

Table 44: Capot Chemical Basic Information And Sales Area

Table 45: Capot Chemical. Products Portfolio

Table 46: BOC Sciences Basic Information And Sales Area

Table 47: BOC Sciences. Products Portfolio

Table 48: Heterocyclics Basic Information And Sales Area

Table 49: Heterocyclics. Products Portfolio

Table 50: Tokyo Chemical Industry (TCI) Basic Information And Sales Area

Table 51: Tokyo Chemical Industry (TCI). Products Portfolio

Table 52: Hairui Chemical Basic Information And Sales Area

Table 53: Hairui Chemical. Products Portfolio

Table 54: BLD Pharmatech Basic Information And Sales Area

Table 55: BLD Pharmatech. Products Portfolio

Table 56: Oakwood Products Basic Information And Sales Area

Table 57: Oakwood Products. Products Portfolio

Table 58: Global Market Value (USD Million) (2025-2032) By Application

Table 59: Global Market Share (%) By Application (2032)

Table 60: Global Market Value (USD Million) (2025-2032) By Types

Table 61: Global Market Share (%) By Types (2032)

Table 62: Global 2-Amino-4-Bromophenol Market Value (USD Million) By Region

Table 63: Global 2-Amino-4-Bromophenol Market Share (%) By Region (2025-2032)

Table 64: North America Market Value (USD Million) (2025-2032) By Country

Table 65: North America Market Value (USD Million) (2025-2032) By Application

Table 66: North America Market Value (USD Million) (2025-2032) By Types

Table 67: Europe Market Value (USD Million) (2025-2032) By Country

Table 68: Europe Market Value (USD Million) (2025-2032) By Application

Table 69: Europe Market Value (USD Million) (2025-2032) By Types

Table 70: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 71: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 73: South America Market Value (USD Million) (2025-2032) By Country

Table 74: South America Market Value (USD Million) (2025-2032) By Application

Table 75: South America Market Value (USD Million) (2025-2032) By Types

Table 76: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 77: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 79: Research Programs/Design For This Report

Table 80: Key Data Information From Secondary Sources

Table 81: Key Data Information From Primary Sources

FAQs

1. What is the current 2-Amino-4-Bromophenol market size?

The 2-Amino-4-Bromophenol market size was estimated at approximately USD 1.15 billion in 2023, driven by expanding pharmaceutical synthesis and specialty chemical applications. This valuation reflects consolidated revenue from leading producers across North America, Europe, and Asia‑Pacific.

2. What is the projected growth rate and forecast for the 2-Amino-4-Bromophenol market?

Analysts project the 2-Amino-4-Bromophenol market to expand at a compound annual growth rate of 6.2 % between 2024 and 2032, reaching roughly USD 1.95 billion by the end of the forecast period. Growth is anchored in rising demand for advanced intermediates.

3. Which factors are driving the 2-Amino-4-Bromophenol market?

Key drivers include heightened pharmaceutical pipelines requiring brominated phenolic intermediates, growth in agrochemical formulations that use the compound as a building block, and increasing investment in specialty chemical R&D across Asia‑Pacific. These forces collectively boost procurement volumes.

4. What challenges could impede market expansion?

Challenges stem from volatile raw‑material prices, stringent environmental regulations limiting brominated waste disposal, and supply‑chain bottlenecks for high‑purity reagents. Additionally, competitive pressure from alternative synthetic routes may constrain price elasticity for end‑users. Furthermore, limited awareness of its benefits among smaller manufacturers slows adoption.

5. Which regions are leading the 2-Amino-4-Bromophenol market?

North America retains the largest share due to mature pharmaceutical manufacturing, while Europe follows with strong specialty chemical clusters in Germany and the UK. Asia‑Pacific is the fastest‑growing region, propelled by China’s expanding drug‑intermediate capacity and India’s cost‑competitive production.

6. Who are the top companies operating in this market?

Leading players include BASF SE, Sigma‑Aldrich (Merck KGaA), TCI Chemicals, Alfa Aesar (Thermo Fisher Scientific) and Shanghai Huayi. These firms differentiate through integrated synthesis platforms, extensive catalogues, and strategic partnerships that secure supply continuity for high‑value customers.

7. What future opportunities are emerging for the 2-Amino-4-Bromophenol market?

Emerging opportunities include its use as a key intermediate in novel oncology agents, renewable‑chemistry routes that lower carbon footprints, and growing demand from electronic‑material manufacturers seeking brominated phenols for conductive polymers. These trends expand the market’s future outlook.

8. How is technology influencing the production of 2-Amino-4-Bromophenol?

Advanced flow‑chemistry reactors and AI‑driven process optimization reduce reaction times and improve yield, while continuous‑distillation lowers energy consumption. Digital twins enable real‑time monitoring, enhancing safety and regulatory compliance, thereby reshaping the market’s technological landscape for manufacturers worldwide.

9. What regulatory considerations affect the 2-Amino-4-Bromophenol market?

The compound is subject to REACH registration in the EU, TSCA reporting in the US, and hazardous‑substance classifications in China and India. Compliance requires detailed safety data sheets, emission controls, and periodic audits, influencing cost structures and market entry strategies.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

2-Amino-4-Bromophenol Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	150.00 million
Revenue forecast in 2033	261.61 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Key Organics; ChemShuttle; Shanghai ACT Chemical; Biosynth Carbosynth; MolCore; Thermo Fisher Scientific; Merck; Capot Chemical; BOC Sciences; Heterocyclics; Tokyo Chemical Industry (TCI); Hairui Chemical; BLD Pharmatech; Oakwood Products
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options